ResearcherShanghai UniversityActive in the last 2 years
Wenxin Qi
Matched on ORCID iD 0009-0004-1642-7188; OpenAlex author ID A5004401087. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 14
2023: 2 papers · 2024: none · 2025: 1 paper
Papers 3
- CTCF enhances pancreatic cancer progression via FLG-AS1-dependent epigenetic regulation and macrophage polarization. Co-author DOI 10.1038/s41418-024-01423-1↗
- High CTCF expression mediated by FGD5-AS1/miR-19a-3p axis is associated with immunosuppression and pancreatic cancer progression. First author DOI 10.1016/j.heliyon.2023.e22584↗
- BHLHE40, a potential immune therapy target, regulated by FGD5-AS1/miR-15a-5p in pancreatic cancer. Co-author DOI 10.1038/s41598-023-43577-x↗
Closest collaborators
The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yihao Liu · 2 shared papers, 2023–2025 · strength 0.36
- Paper CTCF enhances pancreatic cancer progression via FLG-AS1-dependent epigenetic regulation and macrophage polarization. DOI 10.1038/s41418-024-01423-1↗
- Paper High CTCF expression mediated by FGD5-AS1/miR-19a-3p axis is associated with immunosuppression and pancreatic cancer pr… DOI 10.1016/j.heliyon.2023.e22584↗
- Shaohua Song · 2 shared papers, 2023 · strength 0.35
- Jiewei Lin · 1 shared paper, 2025 · strength 0.18
- Jiayu Lin · 1 shared paper, 2025 · strength 0.18
- Yizhi Cao · 1 shared paper, 2025 · strength 0.18
- Shuyu Zhai · 1 shared paper, 2025 · strength 0.18
- Jiancheng Wang · 1 shared paper, 2025 · strength 0.18
- Siyi Zou · 1 shared paper, 2025 · strength 0.18
- Chenlei Wen · 1 shared paper, 2025 · strength 0.18
- Pengyi Liu · 1 shared paper, 2025 · strength 0.18
- Kai Qin · 1 shared paper, 2025 · strength 0.18
- Liu Yang · 1 shared paper, 2025 · strength 0.18
- Baiyong Shen · 1 shared paper, 2025 · strength 0.18
- Yihao Liu · 1 shared paper, 2023 · strength 0.18
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.